Evidence map›Paper›PMID 41768030›Full record

ArticleFrontiers in molecular biosciences2025

A data-driven AI framework for personalized diagnosis, prognosis, and therapeutic optimization in chronic disease management using multimodal big data analytics.

Yu Zhang, Zhujin Song, Qi Cai

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yu ZhangDepartment of Gynaecology, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Zhujin SongDepartment of Pharmacy, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Qi CaiInstitute of Artificial Intelligence, Shandong University of Technology, Zibo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The transformation of chronic disease management is increasingly driven by the integration of AI and multimodal data analytics, enabling precise, individualized, and scalable healthcare interventions. Despite the growing availability of longitudinal and heterogeneous health data, conventional methods are constrained in their ability to model the complex, patient-specific dynamics inherent to chronic conditions. Traditional clinical decision support systems rely on rigid, population-level models that inadequately address inter-patient variability, multi-condition comorbidities, and evolving disease trajectories. Methods: To overcome these limitations, we propose a computational framework that utilizes multimodal big data to enable personalized diagnosis, prognosis, and therapeutic optimization. At the core of this framework is the Patient-Adaptive Transition Tensor Network (PATTN), a tensorized dynamical model that captures individual-specific disease evolution through structured latent state representations and high-order temporal dependencies. Complementing this is the Trajectory-Aligned Intervention Recalibration (TAIR), an adaptive decision-making strategy that continuously aligns predicted and observed health trajectories, facilitating real-time treatment policy refinement. This unified pipeline integrates latent trajectory modeling, condition-aware modular representation, and personalized policy optimization. Results and Discussion: Experimental evaluations on large-scale multimodal datasets demonstrate superior performance in outcome prediction accuracy, intervention personalization, and trajectory alignment, underscoring the practical applicability of the system in chronic care settings. By combining patient-specific temporal modeling with adaptive therapeutic recalibration, this framework represents a significant advancement toward scalable, intelligent, and individualized chronic disease management leveraging AI and big data infrastructures.

Indexed as

AIchronic disease managementmultimodal data analyticspersonalized diagnosisprognosistherapeutic optimization

Identifiers

PMID41768030
PMCPMC12946122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.